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Azomethine complexes derived from 4 (2-aminoethyl) morpholine and their metal(II) complexes have been 
synthesized. The complexes were characterized by spectroscopic techniques and X-ray crystallography. The 
complexes were tested for antibacterial activity against selected nosocomial pathogens of Acinetobacter 
baumannii, Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas 
aeruginosa using the disc diffusion and broth micro-dilution. Overall results showed that the cadmium 
containing complex exhibited considerable antibacterial activities against Acinetobacte baumannii and MRSA. 
Results from the broth micro-dilution assay showed a much higher MIC value of the complex, ranging from 
156.3 μg/mL to 625.0 μg/mL, when compared to the MIC value of antibiotics control of 2.0 μg/mL to 4.0 
μg/mL. The in -vitro results indicate that metal complexes may be potentially utilized as an alternative to 
antibacterial drugs against nosocomial infections caused by both MRSA and A. baumannii.  
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INTRODUCTION 
 Azomethine compounds are more often 
regarded as ligands that will bind with other 
elements such as metallic ions in the synthesis of 
complexes. The presence of nitrogen (N) donor 
atoms in their structure resulted in its unique 
coordination behaviors with metal ions (Vinuelas et 
al., 2011). The chemical coordination geometry of 
complexes that are bound to metallic ions can be 
altered in order to change its chemical properties 
(Shakir et al., 2012). The azomethine complexes 
have been the focus of researchers due to simplicity 
in their synthesis and also the potential of the 
complexes to be used as antimicrobial agents 
(Yamada, 1999). In recent years, many studies 
were conducted on the efficacy of these type of 
metal complexes as potential antimicrobial agents, 
and tested against a variety of bacterial and fungal 
species (Valent et al., 2002, Noyce et al., 2006, 
Reiss et al., 2009, Sabik et al.,2012, Gwaram et al., 
2012, Gupta et al.,2012, Sunitha et al., 2012). 
 In clinical settings, Acinetobacter 
baumannii, Klebsiella pneumoniae, Staphylococcus 
aureus and Pseudomonas aeruginosa are among 
the medically important bacteria that not only cause 
nosocomial infections, but they are also highly 
resistant to multiple antibiotics used in clinical 
treatments (Navon et al., 2005, Defres et al.,2009, 
Sikarwar and Batra 2011, Boon et al.,2011). 
Serious infections caused by Staphylococcus 
aureus are treated with the glycopeptide antibiotics 
such as vancomycin and teicoplanin. However, the 
methicillin-resistant Staphylococcus aureus 
(MRSA) is known to be resistant to multiple 
antibiotics including the antibiotic of last resort for 
the treatment of its infections, vancomycin (Casey 
et al., 2007). Some of the multiple drug-resistant 
strains of Klebsiella pneumoniae are capable of 
producing the extended-spectrum β-lactamase 
enzyme that renders all β-lactam antibiotics 
ineffective (Won et al., 2011). As for 
Acinetobacter baumannii and Pseudomonas 
aeruginosa, both of these pathogenic bacteria are 
feared not only for their ability to grow and survive 
in unfavorable conditions, but also their highly 
intrinsic resistance to most of the available 
antibiotics (Zavascki et al., 2010). More recently, 
bacteria have developed resistance to the virtually 
most drug of choice and this can lead to potential 
treats to society in general. 
 The objective of the study was to 
synthesize, characterize and assess the antibacterial 
activity of Nickel and Cadmium Azomethine 
complexes against selected nosocomial pathogens 
of methicillin-resistant Staphylococcus aureus 
(MRSA), Acinetobacter baumannii (AC), 
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Klebsiella pneumoniae (KB) and Pseudomonas 
aeruginosa (PA) by using the disc diffusion and 
broth micro-dilution. 
 
MATERIALS AND METHODS 
Materials 
All chemicals used in this paper were of 
analytical grades and used without any further 
purification. Nickel(II) and Cadmium(II) acetate, 
Sodium azide, 4-(2-aminoethyl)morpholine and 2-
acetylpyridine were purchased from the Aldrich–
Sigma. Ethanol and Methanol Solvents were 
distilled prior to use. Melting points were 
determined using an MEL-TEMP II melting point 
instrument. Microanalyses were carried out on a 
Perkin-Elmer 2400 elemental analyzer. 1H-NMR 
and 13C-NMR spectra were determined with a 
JEOL Lambda 400 MHz FT-NMR (1H: 400 MHz 
and 13C: 100.4 MHz) spectrometer. Chemical 
shifts are given in δ values (ppm) using TMS as the 
internal standard.  
 
METHODS 
Synthesis of Nickel and Cadmium Complexes  
The complexes were synthesized via in 
situ method as follows:  A mixture of 2-
acetylpyridine (0.20 g, 1.65 mmol) and 4-(2-
aminoethyl)morpholine (0.21 g, 1.65 mmol) in 
ethanol (20 ml) was refluxed for 2 hrs followed by 
addition of a solution of either cadmium(II) acetate 
dihydrate (0.44 g, 1.65 mmol) or of nickel(II) 
acetate tetrahydrate (0.41 g, 1.65 mmol) and 
sodium azide (0.22 g, 3.30 mmol) in a minimum 
amount of water. The resulting solution was 
refluxed for 30 mins, and then left at room 
temperature. The crystals of the complexes (Fig. 1) 
were obtained in 2-3 days; the resulting pure 
crystals were filtered off, washed with cold ethanol 



































Fig. 1: Proposed synthesis scheme for the complexes 
Table 1: Spectroscopic Analysis data for the Complexes characterization 
Analysis Cadmium Complex Nickel Complex 
 
CHN Analysis 
Theory: C, 40.80; H, 5.00; N, 32.94. Found: 
C, 40.92; H, 5.21; N, 33.04. 
Theory: C, 41.85; H, 5.67; N, 28.16. Found: 




2951.03, 2848.69 (C-H), 2044.84 
(N=N=N), 2018.95 (N=N=N), 1648.78 
(C=N), 1437.97 (C-C), 1109.85 (C-N), 
551.73 (M-N). 
3360.55 (OH2), 2943.55, 2880.00 (C-H), 
2074.48, 2031.03 (N=N=N), 1662.25 
(C=N), 1437.62 (C-C), 1113.15 (C-N), 
565.26 (M-N), 452.82 (M-O). 
UV-Vis 
[(DMSO)(nm)] 
246.00 (π→π*); 281.00 (n→π*). 712.00 (d→d*), 608.00 (LMCT); 307.00 





8.681, 8.674 [d, 1H, δ(Ar-H)pyr], 8.281, 
8.268, 8.255, 8.243, 8.231 [m, 2H, δ(Ar-
H)pyr], 7.854 [s, 1H, δ(Ar-H)pyr], 3.791 [s, 
4H, δ(2CH2)], 3.738, 3.731, 3.722 [t, 2H, 
δ(N-CH2)], 2.788, 2.779, 2.769 [t, 6H, 
δ(2CH2)], 2.533 [s, 3H, δ(CH3)]. 
- No Proton NMR due to Paramagnetic nature 
of Nickel  







164.66 [1C, δ(C=N)], 149.02 δ(C), 140.37 
δ(CH), 127.36  δ(CH), 124.31 δ(CH),  
δ(CH)  [5C, δ(Ar-pyr)], 65.43 [2C, 
δ(2CH2)], 58.06 [2C, δ(2CH2)], 53.44 [1C, 
δ(CH2)], 44.46 [1C, δ(CH2)], 15.29 [1C, 
δ(CH3)].  





The nosocomial bacterial pathogens 
originated from clinical settings and were resistant 
to multiple antibiotics. Eight clinical strains from 
four different bacterial pathogens were tested: 
Acinetobacter baumannii (AC) (AC06127, 
AC08121), Klebsiella pneumoniae (KB) (KB88, 
KB198); methicillin-resistant Staphylococus aureus 
(MRSA) (MRSA080425, MRSA08071) and  
Pseudomonas aeruginosa (PA) (PA30, PA42). All 
bacterial strains were obtained from the cultures 
collection of Laboratory of Biomedical Science and 
Molecular Microbiology, Institute of Graduate 
Studies University of Malaya 50603 Kuala Lumpur 
Malaysia.  
 
Kirby-Bauer Disk Diffusion Assay 
 Potential antibacterial activity for the 
synthesized compounds were initially investigated 
using the Kirby-Bauer disc diffusion assay (CLSI, 
2006) against two (2) selected strains from each of 
the bacterial species, namely; MRSA080425 and 
MRSA08071 for MRSA; KB88 and KB198 for 
K.pneumoniae; AC06127 and AC08121 for 
A.baumannii; and PA30 and PA42 for 
P.aeruginosa. For inoculum preparation, overnight 
bacterial culture were suspended in saline solution 
containing 0.85% NaCl (w/v) and diluted to match 
the 0.5 McFarland turbidity standards of 
approximately ‘1 x 108’ CFU/mL.  The prepared 
inoculum was streaked with sterile swab onto the 
surface of cation-adjusted Mueller Hinton II agar 
(CAMHA; Oxoid) to obtain bacterial lawn. 
Respective antibacterial compounds of 10,000 
μg/mL were transferred onto sterile paper disks 
(Thermo Fisher, 6.0 mm diameter). Dimethyl 
Sulfoxide (DMSO) was used as the solvent and 
was transferred onto disk as negative control. The 
commercial antibiotics disks (Oxoid) of polymyxin 
B sulfate (300.0 units) and vancomycin (30.0 μg) 
were included as positive controls. The disks were 
placed onto agar surfaces of respective bacterial 
lawn of inocula. Inhibition zones (in mm) around 
disks were observed and measured after 18 hours 
of incubation of the plates at 37 oC. Larger 
inhibition zones after incubation indicated more 
potent antibacterial activity against the tested 
bacterial strains. The compound containing the 
metal cadmium had shown the largest inhibition 
zones and was selected for MIC determination in 




 The minimum inhibitory concentrations (MIC) 
of the compound were determined through the 
broth micro-dilution assay (CLSI 2006) with 96-
wells microtiter plates. Selected susceptible 
overnight bacterial cultures were suspended in 
cation-adjusted Mueller Hinton II broth (CAMHB; 
BBL) before being diluted in similar broth to the 
concentration of approximately 1 x 108 CFU/mL 
(equivalent to 0.5 McFarland turbidity standards) 
for the inoculum preparation. Two-fold serial 
dilution of the tested Schiff base compound; the 
Cd(II) complex was prepared in sterile distilled 
water in the 96-wells microtiter plate with the 
highest concentration starting from 2,500.0 μg/mL 
in duplicate rows. The commercial antibiotics 
powder of polymyxin B sulfate (Sigma) and 
vancomycin (Sigma) were prepared beforehand and 
included as positive controls with the highest 
concentration starting from 16.0 μg/mL. Wells 
containing bacterial suspensions and wells without 
bacterial suspensions and compound were used as 
positive growth control and broth sterility control, 
respectively. The prepared inoculum was 
transferred to all wells except the broth sterility 
control wells in 1:1 dilution ratio. The inoculated 
plates were incubated at 37 oC for 18 hours. After 
incubation, the turbidity of wells containing the 
compound was visually compared to the turbidity 
in wells without compound to determine the growth 
end points. The MIC is the lowest concentration of 
the compound that completely inhibits the growth 
of organism in wells. 
 
RESULTS AND DISCUSSION   
The spectroscopic analysis data of 
complexes are summarized in (Table 1). The result 
percentages of C, H and N obtained are in 
agreement with calculated values. The IR spectra of 
all the complexes possess a characteristic 
absorption bands in the region of 1648.78 and 
1662.25cm-1 for Cd(II) and Ni(II) respectively 
which is attributed to the C=N functional group 
stretching vibration (Gwaram and Hassandarvish 
2014). Another very strong absorption at the region 
of 2044.84, 2018.95 and 2074.48, 2031.03 
corresponding to (N=N=N) functional group 
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frequencies for Cd(II) and Ni(II) respectively 
(Gwaram 2017). 
 
Fourier transform-Nuclear Magnetic Resonance 
(FT-NMR) 
The proton Nuclear Magnetic Resonance 
(NMR) characteristic chemical frequencies 
observed in the region 8.681-7.854 ppm, were 
assigned to the aromatic ring protons for Cd(II) 
complex (Gwaram et al., 2012). The other single 
peak appeared at 2.533 ppm was attributed to 
δ(CH3) representing the methyl on the carbonyl 
group (Mustafa et al., 2009). In the 13C Nuclear 
Magnetic Resonance (NMR) spectra the signal at 
region of 164.66ppm is assigned to the azomethine 
(C=N) carbon atoms for Cd(II) complex (Mustafa 
et al., 2009). Subsequent signals for the aromatic 
ring carbon atoms were determined in the region of 








ethylidene] ethanamine-κ3N,N’,N”} bis (azido-
κN) cadmium (II) 
The single crystal of this compound has 
been obtained via the complexation of cadmium(II) 
azide by the N,N’,N”-tridentate ligand, 2-
morpholino-N-[1-(2-
pyridyl)ethylidene]ethanamine, which had itself 
been prepared from the condensation of 4-(2-
aminoethyl)morpholine and 2-acetylpyridine. In the 
compound, the Cd(II) atom is octahedrally 
coordinated by the N,N’,N”-tridentate Schiff base 
ligand and two terminal azide N atom. The adjacent 
Cd(II) ions are coordinated by one additional water 
ligand (Fig. 2). The geometry of the complex can 
be defined as distorted octahedral geometry with 
one of the water molecule act as coordinated ligand 
to have complete the geometry. The cadmium 
complex crystal system is monoclinic with space 
group P21/c and a/Å, b/Å, c/Å of 17.2330(8), 
6.6786(3), 30.1578(14) whereas 90.00, 
91.8670(10) and 90.00 corresponding to α/°, β/° 
and  γ/° respectively (Table 2). 
 
 




In this complex crystal system is triclinic 
with space group PI and 90.00, 90 and 90.00 
corresponding to α/°, β/° and γ/° respectively 
(Table 2). The atom is octahedrally coordinated by 
the N,N’,N”-tridentate Schiff base ligand and one 
terminal azide N atom. In the crystal, adjacent 
Ni(II) ions are linked by the azide N:N-bridges into 
polymeric chains along the c axis. The azide ions 
act as either bridging or terminal ligands. However, 
different from the doubly bridged dimeric structure 
of the former, in the present structure the bridging 
azide ligands singly bridge the adjacent metal 
centers into infinite chains along the c axis (Fig. 3). 
Within this coordination polymer, Two azide N:N-
bridges, one terminal azide N atom and the Ni(II) 
ion is coordinated by one additional water ligand to 
have an octahedral geometry. 




Fig. 3: crystal structure for [Ni2(LMA)2(N3)2(H2O)2] 
Table 2: Crystal Data and refinement parameters for the synthesized complexes 
Identification code  [Cd(N3)2(C13H19N3O)]-H2O [Ni2(LMA)2(N3)2(H2O)2] 
Empirical formula  C13H19CdNO  C13HN9ONi  
Formula weight  317.69  357.94  
Temperature/K  373(2)  373(2)  
Crystal system  monoclinic  triclinic  
Space group  P21/c  P1  
a/Å  6.6786(3)  10.4169(4)  
b/Å  17.2330(8)  15.0746(6)  
c/Å  30.1578(14)  20.7751(9)  
α/°  90.00  90.00  
β/°  91.8670(10)  90.00  
γ/°  90.00  90.00  
Volume/Å3  3469.1(3)  3262.3(2)  
Z  12  8  
ρcalcmg/mm3  1.825  1.458  
m/mm-1  1.866  1.209  
F(000)  1920.0  1424.0  
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Crystal size/mm3  0.28 × 0.11 × 0.08  0.19 × 0.11 × 0.05  
2Θ range for data collection  2.7 to 53.98°  1.96 to 60.08°  
Index ranges  -8 ≤ h ≤ 8, -18 ≤ k ≤ 22, -38 ≤ l ≤ 38  -14 ≤ h ≤ 14, -20 ≤ k ≤ 20, -29 ≤ l ≤ 
28  
Reflections collected  27005  34671  
Independent reflections  7584[R(int) = 0.0343]  30044[R(int) = 0.0553]  
Data/restraints/parameters  7584/0/453  30044/3/753  
Goodness-of-fit on F2  0.810  1.828  
Final R indexes [I>=2σ (I)]  R1 = 0.0305, wR2 = 0.0854  R1 = 0.1362, wR2 = 0.3318  
Final R indexes [all data]  R1 = 0.0377, wR2 = 0.1021  R1 = 0.1667, wR2 = 0.3515  
Largest diff. peak/hole /e Å-3  0.75/-0.94  8.48/-2.13  
UV-Visible Spectroscopy  
Nickel(II), which has d
8 
configuration, 
commonly exhibits octahedral, square planar and 
tetrahedral coordination geometries. Octahedral 
geometry generally occurs for nickel(II) with a 
coordination number of six. The electronic spectra 
of Ni(II) complexes [Ni(LMA)(N3)3] showed d-d 
transitions in the region of 279, 307, 628 and 712 
(Table 1, Fig. 4). These are assigned to the 
transitions 3T1(F) → 3A2(F), 3T1(F) → 3T1(P) and 3T1(F) 
→ 3T2(F) consistent with distorted octahedral 
geometry. 
 
Fig. 4: electronic spectra for Ni2(LMA)2(N3)6 
The formation of the metal nitrogen bond 
stabilizes the electron pair on the nitrogen atoms, 
i.e., the energy of the nonbonding n orbital is 
lowered and the transition occurs at a lower 
wavelength. The absorption peak from 
approximately 400 nm to 600 nm means that the 
compound absorbs light in the violet-blue-green 
range. The sum of the non-absorbed, or reflected, 
wavelengths gives the products different colors.  
 
Antibacterial Activity Results 
 Azomethine complexes were screened for 
antibacterial activity against multiple drug-resistant 
nosocomial bacterial pathogens, namely; 
Acinetobacter baumannii (AC), Klebsiella 
pneumoniae (KB), methicillin-resistant 
Staphylococcus aureus (MRSA) and Pseudomonas 
aeruginosa (PA).  The objective of the study was to 
determine the antibacterial activity of the 
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complexes by three approaches; namely the disc 
diffusion and broth micro-dilution. 
 In the initial screening, the synthesized 
compounds were tested against bacterial strains of 
A. baumannii, K. pneumoniae, MRSA and P. 
aeruginosa, with two randomly selected isolates 
from each bacterial species. Distinct clear zones 
indicating growth inhibition were observed from 
the complexes containing metal elements of nickel 
(Ni) and cadmium (Cd) (Table 3). Susceptible 
bacterial strains to those complexes include KB88, 
KB198, MRSA080425, MRSA08071, AC06127, 
and AC08121. However, there was no inhibition 
zone observed for P. aeruginosa for all of the 
compounds tested (Figure 5a-b). The antibiotics 
polymyxin B and vancomycin were included as 
control. Based on the results, the Cd(II) metal 
complex was more potent than the other 
compounds tested as it inhibited the growth of six 
bacterial strains  (AC06127, AC08121, KB88, 
KB198, MRSA080425 and MRSA08071), 
resulting in 100% clear inhibition zones (no 
bacterial growth within the clear zones) (Figure 5c-
d).  
 The metal complex showed antibacterial 
effect comparable to the antibiotics used. The 
enhanced antimicrobial activity of metal complexes 
was extensively studied (Mohamed et al., 2011, 
Aiyelabola et al., 2012). Based on chelation theory, 
the enhancement is due to the increased lipophilic 
nature of the metal complex, achieved by the 
overlapping of ligand orbital with metal orbital in 
the complex, which causes partial sharing of the 
positive charge of metals with the donor groups on 
ligands. This coordination chemistry reduces the 
polarity of metal and thus increasing the lipophilic 
nature of the metal to the lipid layer of bacterial 
cell membrane (Nishat et al., 2011). Due to the 
highly negative-charged LPS on the cell walls of 
Gram-negative bacteria and the opposite charges of 
both the cationic metal ions and cationic peptides, 
metal ions will be adsorbed to bacterial cell 
surfaces through passive biosorption (Chakravarty 
and Banerjee, 2012). The heavy metal cadmium 
was described to disrupt normal cellular processes 
of living organisms by binding to different cellular 
target sites (Wang et al., 2010) and the damaging 
effect towards membrane structure when cadmium 
binds to phosphate ligands present on the 
membrane (Vig et al., 2003). Based on the 
screening result, the most active compound, which 
was the cadmium-containing complex, LMA Cd-N3 
was chosen to determine its activity on the isolates 
of bacteria that were sensitive to the mentioned 
compound. The minimum inhibitory concentrations 
(MICs), of the metal complex were determined in 
broth micro-dilution assay  
Bacterial strains of MRSA 
(MRSA080425), K. pneumoniae (KB88) and A.  
(AC08121) that were susceptible to the metal 
complex LMA Cd-N3 were selected for further 
testing in broth micro-dilution assay. Results from 
the broth micro-dilution assay showed a much 
higher MIC value of LMA Cd-N3, ranging from 
156.3 μg/mL to 625.0 μg/mL, when compared to 
the MIC value of antibiotics control of 2.0 μg/mL 
to 4.0 μg/mL (Table 4). 
 
Table 3. Zones of inhibition from antimicrobial disc diffusion assay. Readings of 6.0 mm represents disk size, 
no inhibition zone observed. Schiff base complexes were tested at 10,000 μg/mL. Disc concentration of 
polymyxin B tested was 300.0 units; concentration of vancomycin was 30.0 μg. Polymyxin B and vancomycin 
were not determined on P. aeruginosa, represented by ‘n.d’. 
  Zones of inhibition (mean value to the nearest mm) 


















Ctrl 0.85% saline 6 6 6 6 6 6 6 6 
Ctrl DMSO 6 6 6 6 6 6 6 6 
Ctrl Polymyxin B 6 6 15 15 16 15 n.d n.d 
Ctrl Vancomycin 16 17 6 6 6 6 n.d n.d 
S1 LMA Ni-N3 6 9 10 12 6 6 6 6 
















Fig. 5. Images showing the Sample of antibacterial inhibition zones of compounds of Azomethine 
complex tested against bacterial strains of KB88 (A); KB198 (B); MRSA080425 (C) and 
MRSA08071 (D);  
 
Table 4. Minimum inhibitory concentration (MIC) of antibacterial compounds tested in the broth 
micro-dilution assay 
Bacterial strains 
Minimum inhibitory concentration (MIC) (μg/mL) 
Antibacterial compounds 
LMA Cd-N3 Vancomycin Polymyxin B 
MRSA 625.0 4.0 - 
KB 312.5 - 2.0 
AC 156.3 - 2.0 
 
CONCLUSION 
 The results obtained from the assays 
showed that the synthesized compounds of Schiff 
base complex coupled with Ni(II) and Cd(II) ions 
exhibited antibacterial activity against both clinical 
strains of Gram-positive (represented by MRSA)  
and Gram-negative bacteria (represented by A. 
baumanii, P. aeruginoa, K. pnumioniae)  tested in 
the study. The findings implied that the cadmium-
containing Schiff base complex represents a good 
candidate for future research leading to the 
development of novel antibacterial drugs for the 
treatment of diseases caused by both the multiple 
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